1. Home
  2. NNNN vs CBL Comparison

NNNN vs CBL Comparison

Compare NNNN & CBL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Anbio Biotechnology Class A Ordinary Shares

NNNN

Anbio Biotechnology Class A Ordinary Shares

HOLD

Current Price

$25.50

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Logo CBL & Associates Properties Inc.

CBL

CBL & Associates Properties Inc.

HOLD

Current Price

$47.72

Market Cap

1.4B

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
NNNN
CBL
Founded
2021
1978
Country
Germany
United States
Employees
27
500
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.4B
IPO Year
N/A
1995

Fundamental Metrics

Financial Performance
Metric
NNNN
CBL
Price
$25.50
$47.72
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$45.00
AVG Volume (30 Days)
12.8K
162.7K
Earning Date
04-07-2026
05-07-2026
Dividend Yield
N/A
4.00%
EPS Growth
N/A
132.09
EPS
N/A
4.34
Revenue
N/A
$578,373,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$446.57
$10.10
Revenue Growth
N/A
12.18
52 Week Low
$7.03
$24.03
52 Week High
$55.65
$45.86

Technical Indicators

Market Signals
Indicator
NNNN
CBL
Relative Strength Index (RSI) 49.55 75.18
Support Level $26.31 $36.41
Resistance Level $30.21 N/A
Average True Range (ATR) 2.10 1.23
MACD -0.28 -0.04
Stochastic Oscillator 20.78 95.99

Price Performance

Historical Comparison
NNNN
CBL

About NNNN Anbio Biotechnology Class A Ordinary Shares

Anbio Biotechnology is a medical device company focused on in vitro diagnostics. The company's mission is to change the diagnostics market by personalizing and decentralizing the current diagnostic solutions for faster diagnosis to improve patient prognosis. The company proposes this by providing accessible and affordable diagnostic solutions globally at the forefront of science and offering laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions. The business planning is to focus on validating and commercializing the existing portfolio of in vitro diagnostic products, as well as generating additional data required to support regulatory submissions and compliance, including under frameworks such as the In Vitro Diagnostic Regulation (IVDR).

About CBL CBL & Associates Properties Inc.

CBL & Associates Properties Inc is a real estate investment trust. The company engages in the ownership, development, acquisition, leasing, management and operation of regional shopping malls, outlet centers, lifestyle centers, open-air centers and other properties. CBL's sales predominantly derive from leasing arrangements with retail tenants. The company also generates revenue from management and development fees, as well as sales of its real estate assets. CBL expands its portfolio of assets through activities such as redevelopment, renovation, and expansion.

Share on Social Networks: